Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Paulus Kirchhof, Dietrich Andresen, Ralph Bosch, Martin Borggrefe, Thomas Meinertz, Ulli Parade, Ursula Ravens, Alexander Samol, Gerhard Steinbeck, Andras Treszl, Karl Wegscheider, Günter Breithardt

Research output: Contribution to journal › Article › peer-review

91 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial'. Together they form a unique fingerprint.

Medicine & Life Sciences